Ratings Trupanion, Inc.

Equities

TRUP

US8982021060

Real-time Estimate Cboe BZX Other stock markets 03:23:50 2024-04-26 pm EDT			5-day change	1st Jan Change
23.82 ^USD	+2.19%		+6.10%	-21.93%

Apr. 22	Trupanion Introduces truInsights: A Pet Health Data Initiative	CI
Apr. 05	Piper Sandler Cuts Price Target on Trupanion to $28 From $32, Maintains Overweight Rating	MT

Strengths

Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The company appears highly valued given the size of its balance sheet.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TRUPANION, INC.	-23.60%	975M		C
BUPA ARABIA FOR COOPERATIVE INSURANCE COMPANY	+13.21%	9.63B		B-
MEDIBANK PRIVATE LIMITED	0.00%	6.5B		C+
THE COMPANY FOR COOPERATIVE INSURANCE	+16.74%	6.08B		C
OSCAR HEALTH, INC.	+95.52%	4.23B		-
NIB HOLDINGS LIMITED	-1.08%	2.38B		B+
RELIGARE ENTERPRISES LIMITED	+1.29%	884M	-	D+
AMANA COOPERATIVE INSURANCE COMPANY	+7.80%	162M	-	-
PT LIPPO GENERAL INSURANCE TBK	-8.15%	68.85M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes